Javascript must be enabled to continue!
Influence of antepartum hemorrhage on placenta previa: A multi-center, retrospective cohort study
View through CrossRef
Abstract
BACKGROUND
Placenta previa can be a serious, life-threatening obstetric complication that causes painless but potentially catastrophic bleeding. It is unclear as to whether the frequency of antepartum hemorrhage (APH) relative to the specific gestational week in placenta previa will lead to negative perinatal outcomes. The purpose of the present study was to determine the relationship between APH and gestational week number, and to ascertain the different perinatal outcomes in women with placenta previa.
METHODS
This was a multi-center, retrospective study in which we enrolled all women with placenta previa between October of 2015 and September of 2018. Patients with placenta previa were divided into two groups: women with APH and women without APH.
RESULTS
A total of 247 patients were included in this study: 121 women with APH and 126 women without. The incidence of APH was 49.0% (121/247). The mean bleeding frequency was 2.2 ± 1.3 (mean ± SD), with the majority having experienced a one-time bleeding episode (36.4%, 44/121), followed by 26.4% with 2 episodes (32/121), and 23.1% with 3 (28/121). The APH was distinct in every gestational-week category, with bleeding occurring at 31.4 ± 3.3 weeks, ranging from 24 to 37 gestational weeks. The incidence of bleeding varied from 2.6–14.6%, with the highest incidence at 32 gestational weeks. Patients categorized as having complete placental coverage included a greater number of women experiencing bleeding than women who did not bleed (72.9% vs 47.4%, P < 0.001), indicating that a complete placenta was an independent risk factor for APH (odds rations [OR], 4.17; 95% confidence interval [CI], 1.805–9.634). In addition, although APH did not augment the rates of hysterectomy (6.6% vs 7.1%, P = 0.869), it was associated with critical neonatal outcomes that included lower weight, lower Apgar score at 1 minute, preterm age, and more frequent neonatal intensive care unit admissions (P < 0.05).
CONCLUSIONS
The gestational week and frequency of each APH varied in patients with placenta previa and might result in an increase in adverse maternal and neonatal outcomes. The 32nd gestational week appeared to be the most precarious time—exhibiting the highest incidence of bleeding—and we consider complete placenta previa to be an independent risk factor for APH.
Title: Influence of antepartum hemorrhage on placenta previa: A multi-center, retrospective cohort study
Description:
Abstract
BACKGROUND
Placenta previa can be a serious, life-threatening obstetric complication that causes painless but potentially catastrophic bleeding.
It is unclear as to whether the frequency of antepartum hemorrhage (APH) relative to the specific gestational week in placenta previa will lead to negative perinatal outcomes.
The purpose of the present study was to determine the relationship between APH and gestational week number, and to ascertain the different perinatal outcomes in women with placenta previa.
METHODS
This was a multi-center, retrospective study in which we enrolled all women with placenta previa between October of 2015 and September of 2018.
Patients with placenta previa were divided into two groups: women with APH and women without APH.
RESULTS
A total of 247 patients were included in this study: 121 women with APH and 126 women without.
The incidence of APH was 49.
0% (121/247).
The mean bleeding frequency was 2.
2 ± 1.
3 (mean ± SD), with the majority having experienced a one-time bleeding episode (36.
4%, 44/121), followed by 26.
4% with 2 episodes (32/121), and 23.
1% with 3 (28/121).
The APH was distinct in every gestational-week category, with bleeding occurring at 31.
4 ± 3.
3 weeks, ranging from 24 to 37 gestational weeks.
The incidence of bleeding varied from 2.
6–14.
6%, with the highest incidence at 32 gestational weeks.
Patients categorized as having complete placental coverage included a greater number of women experiencing bleeding than women who did not bleed (72.
9% vs 47.
4%, P < 0.
001), indicating that a complete placenta was an independent risk factor for APH (odds rations [OR], 4.
17; 95% confidence interval [CI], 1.
805–9.
634).
In addition, although APH did not augment the rates of hysterectomy (6.
6% vs 7.
1%, P = 0.
869), it was associated with critical neonatal outcomes that included lower weight, lower Apgar score at 1 minute, preterm age, and more frequent neonatal intensive care unit admissions (P < 0.
05).
CONCLUSIONS
The gestational week and frequency of each APH varied in patients with placenta previa and might result in an increase in adverse maternal and neonatal outcomes.
The 32nd gestational week appeared to be the most precarious time—exhibiting the highest incidence of bleeding—and we consider complete placenta previa to be an independent risk factor for APH.
Related Results
Comparative Study of Fetomaternal Outcome in Abruptio Placenta and Placenta Previa
Comparative Study of Fetomaternal Outcome in Abruptio Placenta and Placenta Previa
Background: Abruptio placenta and placenta previa are obstetric complications associated with significant risks for both the fetus and the mother, potentially leading to severe hem...
Risk Factors and Perinatal Outcomes for Placenta Praevia at Delivery in nulliparas: a Retrospective Case-control Study
Risk Factors and Perinatal Outcomes for Placenta Praevia at Delivery in nulliparas: a Retrospective Case-control Study
Abstract
Background
Placenta previa leads to dangerous obstetrical outcomes, including obstetrical hemorrhage and preterm birth, and its rate is still increasing.T...
Placenta Previa a Lethal Disease: A Correlation With Uterine Scaring
Placenta Previa a Lethal Disease: A Correlation With Uterine Scaring
Placenta previa is the main cause of fetomaternal morbidity and mortality globally. Multiparity, advanced maternal age, infertility treatments and recurrent abortions has been link...
Effects of antepartum hemorrhage on maternal and perinatal adverse outcomes in Northern Ethiopia: a retrospective cohort study
Effects of antepartum hemorrhage on maternal and perinatal adverse outcomes in Northern Ethiopia: a retrospective cohort study
Abstract
Background
Antepartum hemorrhage (APH) complicates 2–5% of all pregnancies and is the main cause of fetal and ma...
Fetomaternal outcome in patients with placenta previa
Fetomaternal outcome in patients with placenta previa
Objectives: To assess maternal and fetal morbidity associated with placenta previa and morbidly adherent placenta (MAP).
Methods: All patients with placenta previa who delivered i...
Maternal and neonatal outcomes of repeated antepartum bleeding in 493 placenta previa cases: a retrospective study
Maternal and neonatal outcomes of repeated antepartum bleeding in 493 placenta previa cases: a retrospective study
Abstract
Background Placenta previa (PP) is a serious complication of late pregnancy. Exploring the effect of antepartum bleeding caused by PP on pregnancy outcomes is very...
Determinants of Placenta Previa among Pregnant Women Delivered in Public Hospitals South Ethiopia: Unmatched Case-Control Study
Determinants of Placenta Previa among Pregnant Women Delivered in Public Hospitals South Ethiopia: Unmatched Case-Control Study
v> Background: Placenta previa is one of the serous obstetric complications in which the placental tissue abnormally implants the lower uterine segment partially or totally. Alt...
Incidence, associated factors and outcomes of antepartum hemorrhage at Ayder Comprehensive Specialized Hospital and Mekelle General Hospital, Mekelle, Tigray, Ethiopia
Incidence, associated factors and outcomes of antepartum hemorrhage at Ayder Comprehensive Specialized Hospital and Mekelle General Hospital, Mekelle, Tigray, Ethiopia
Introduction: The leading cause of maternal mortality in world is obstetric hemorrhage. Antepartum hemorrhage (APH) is defined as bleeding from or into the genital tract after 28we...

